Deere, Amgen, Copart And More: CNBC's 'Final Trades'
Portfolio Pulse from Avi Kapoor
CNBC's 'Final Trades' highlighted Deere & Company, Amgen, iShares U.S. Healthcare ETF, and Copart. Analysts have adjusted price targets for Deere and Amgen, while Copart's recent earnings missed estimates. All mentioned stocks saw gains in Wednesday's session.
October 10, 2024 | 12:49 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Copart, Inc. was chosen as a final trade despite missing earnings estimates. The stock gained 2.6% to settle at $55.84.
Despite missing earnings estimates, Copart's selection as a final trade and subsequent stock gain indicate resilience and investor interest.
CONFIDENCE 75
IMPORTANCE 65
RELEVANCE 75
POSITIVE IMPACT
Amgen Inc. was noted for its strong pipeline. Barclays raised its price target from $300 to $315, maintaining an Equal-Weight rating. The stock gained 1.5% to close at $322.41.
Amgen's strong pipeline and the price target increase by Barclays indicate positive outlook, contributing to the stock's gain.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Deere & Company was highlighted as a final trade on CNBC. Citigroup raised its price target from $395 to $420, maintaining a Neutral rating. The stock gained 1.3% to close at $405.48.
Deere was highlighted as a final trade, and Citigroup's price target increase suggests positive sentiment. The stock's gain reflects investor optimism.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
iShares U.S. Healthcare ETF was selected as a final trade. The ETF gained 1% during Wednesday's session.
The ETF's selection as a final trade and its gain suggest positive investor sentiment towards the healthcare sector.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 60